Global mRNA analysis to determine a transcriptome profile of cancer stemness in a mouse model

Anticancer Research

Volumn 27, Issue 3 A, 2007, Pages 1319-1324

  Heffron, Cynthia C B B ^a   Gallagher, Michael F ^a   Guenther, Simone ^b   Sherlock, Jon ^b   Henfrey, Richard ^b   Martin, Cara ^a   Sheils, Orla ^a   O'Leary, John J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b APPLIED BIOSYSTEMS   (United States)

Author keywords

Microarray; Stem cells; Teratocarcinoma

Indexed keywords

DECORIN; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTOME;

ANGIOGENESIS; ANIMAL CELL; CANCER STEM CELL; CARCINOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; TERATOCARCINOMA; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TERATOCARCINOMA; TRANSCRIPTION, GENETIC; TUMOR STEM CELLS;

EID: 34249301760     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Trosko JE, Chang C-C, Upham BL and Tai M-H: The role of human adult stem cells and cell-cell communication in cancer chemoprevention and chemotherapy strategies. Mutat Res 591: 187-197, 2005.
2. Pierce GB: Neoplasms, differentiations and mutations. Am J Pathol 77: 103-118, 1974.
3. Gudjonsson T and Magnusson MK: Stem cell biology and the cellular pathways of carcinogenesis. APMIS 113: 922-929, 2005.
4. Bonnet D and Dick JE: Human acute myeloid leukemia is organised as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737, 1997.
5. Collins AT, Berry PA, Hyde C, Stower MJ and Maitland NJ: Prospective identification of tumourigenic prostate cancer stem cells. Cancer Res 65: 10946-10951, 2005.
6. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003.
7. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB: Identification of human brain tumour initiating cells. Nature 432: 396-401, 2004.
8. Radtke F and Clevers H: Self-renewal and cancer of the gut: Two sides of a coin. Science 307: 1904-1909, 2005.
9. Houghton J, Morozov A, Smirnova I and Wang TC: Stem cells and cancer. Semin Cancer Biol 2006 May 4; [Epub ahead of print].
10. Gibbs CP, Kukekov VG, Reith JD, Tchigrinova O, Suslov ON, Scott EW, Ghivizzani SC, Ignatova TN and Steindler DA: Stem-like cells in bone sarcomas: Implications for tumorigenesis. Neoplasia 7: 967-976, 2005.
11. Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 414: 105-111, 2001.
12. Astigiano S, Damonte P, Fossati S, Boni L and Barbieri O: Fate of embryonal carcinoma cells injected into postimplantation mouse embryos. Differentiation 73: 484-490, 2005.
13. Andrews PW: From teratocarcinomas to embryonic stem cells. Philos Trans R Soc Lond B Biol Sci 357: 405-417, 2002.
14. Reiner A, Yekutieli D and Benjamini Y: Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19: 368-375, 2003.
15. Thomas PD, Kejariwal A, Campbell MJ, Mi H, Kiemer K, Guo N, Ladunga I, Ulitsky-Lazareva B, Muruganujan A, Rabkin S, Vandergriff JA and Doremieux O: Panther: A browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res 31: 334-341, 2003.
16. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC and Melton DA: "Stemness": Transcriptional profiling of embryonic and adult stem cells. Science 298: 597-600, 2002.
17. Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA and Lemischka IR: A stem cell molecular signature. Science 298: 601-604, 2002.
18. Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J and Terzis AJA: The origin of the cancer stem cell: Current controversies and new insights. Nat Rev Cancer 5: 899-904, 2005.
19. Huff CA, Matsui WH, Smith BD and Jones RJ: Strategies to eliminate cancer stem cells: Clinical implications. Eur J Cancer 42: 1293-1297, 2006.
20. Sell S: Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 51: 1-28, 2004.
21. Zhang M and Rosen JM: Stem cells in the etiology and treatment of cancer. Curr Opin Genet Dev 16: 60-64, 2006.
22. Koestenbauer S, Zech NH, Juch H, Vanderzwalmen P, Schoonjans L and Dohr G: Embryonic stem cells: Similarities and differences between human and murine embryonic stem cells. Am J Reprod Immunol 55: 169-180, 2006.
23. Theodosiou A and Ashworth A: Map kinase phosphatases. Genome Biol 3: reviews 3009, 2002.
24. Hoornaert I, Marynen P, Goris J, Sciot R and Baens M: Mapk phosphatase dusp16/mkp-7, a candidate tumor suppressor for chromosome region 12p12-13, reduces bcr-abl-induced transformation. Oncogene 22: 7728-7736, 2003.
25. Yu W, Imoto I, Inoue J, Onda M, Emi M and Inazawa J: A novel amplification target, dusp26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 mapk activity. Oncogene 2006 Aug 21; [Epub ahead of print].
26. Lyon MA, Ducruet AP, Wipf P and Lazo JS: Dual-specificity phosphatases as targets for antineoplastic agents. Nat Rev Drug Discov 1: 961-976, 2002.
27. Stewart R, Stojkovic M and Lako M: Mechanisms of self-renewal in human embryonic stem cells. Eur J Cancer 42: 1257-1272, 2006.
28. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
29. Iozzo RV: Matrix proteoglycans: From molecular design to cellular function. Annu Rev Biochem 67: 609-652, 1998.